Wedbush Issues Pessimistic Outlook for ORIC Earnings
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Research analysts at Wedbush dropped their Q1 2025 earnings per share (EPS) estimates for shares of ORIC Pharmaceuticals in a research note issued to investors on Tuesday, February 18th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.52) for the […]
ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC – Free Report) – Research analysts at Wedbush dropped their Q1 2025 earnings per share (EPS) estimates for shares of ORIC Pharmaceuticals in a research note issued to investors on Tuesday, February 18th. Wedbush analyst D. Nierengarten now expects that the company will post earnings per share of ($0.52) for the […]
